Bioreactor-grown exo- and endo-β-glucan from Malaysian Ganoderma lucidum: An in vitro and in vivo study for potential antidiabetic treatment

This study aims to identify the roles of exo-β-glucan (EPS-BG) and endo-β-glucan (ENS-BG) extracted from Ganoderma lucidum (GL) in inhibiting the alpha-glucosidase enzyme, a target mechanism for postprandial hyperglycaemia regulation. Upscale production of GL was carried out using a 10 L bioreactor....

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullah, Nur Raihan, Mohd Nasir, Mohd Hamzah, Azizan, Nur Hafizah, Wan-Mohtar, Wan Abd Al Qadr Imad, Sharif, Faez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452895/
https://www.ncbi.nlm.nih.gov/pubmed/36091430
http://dx.doi.org/10.3389/fbioe.2022.960320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452895/
https://www.ncbi.nlm.nih.gov/pubmed/36091430
http://dx.doi.org/10.3389/fbioe.2022.960320

Ejemplares similares